1258391-83-1Relevant articles and documents
Development of 'DFG-out' inhibitors of gatekeeper mutant kinases
Choi, Hwan Geun,Zhang, Jianming,Weisberg, Ellen,Griffin, James D.,Sim, Taebo,Gray, Nathanael S.
scheme or table, p. 5297 - 5302 (2012/09/07)
HG-7-85-01(22) and HG-7-86-01(26) are thiazolo[5,4-b]pyridine containing type II tyrosine kinase inhibitors with potent cellular activity against both wild-type and 'gatekeeper' mutant T315I- Bcr-Abl. Here we report on the 'hybrid design' concept and subs